Immunocore Holdings plc

NASDAQ:IMCR

Biotechnology

Healthcare
$27.51 +0.63%

+$0.18 today

Market cap
$1.42B
Beta
0.75
P/E (TTM)
-77.5
EPS (TTM)
-$0.37
52W Low $27.56High $40.72

Volume 0.30M

Average 0.40M

IMCR Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Immunocore Holdings plcNASDAQ: IMCR

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 52.93M shares rose 1.9% year over year, ahead of the -0.4% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 5.1% from the prior quarter. Over 3 fiscal years it compounded at +3.3% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.9% holds above the trailing-twelve-month pace of -0.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
52.93M+5.1% QoQ
Last fiscal yearDec 2025
50.35M+0.7% YoY
LTMMar 2026
50.99M-0.4% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.9%——
1 year+0.7%——
3-year CAGR+3.3%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
50.35M USD
Year-over-year change
+0.7%

Weighted Avg Shares (Diluted) vs competitors

How IMCR compares with its peers on the latest reported figures

  • IMCR's LTM Mar 2026 weighted avg shares (diluted) of 50.99M shares is the lowest of the 11 companies compared; the peer median is 105.22M shares.
  • Its year-over-year change of -0.4% is the lowest of 11, against a peer median of +9.7%.
  • Over three fiscal years its annual growth of +3.3% compares with a peer median of +10.9%.
IMCR Competitors Peer median
Weighted Avg Shares (Diluted) for IMCR and competitors
Company Period LTM YoY 3-year CAGR
IBRXImmunityBio, Inc.LTM Sep 20261.03B +20.6%+32.0%
BNTXBioNTech SELTM Jun 2026247.64M +2.5%-1.1%
IMMPImmutep LimitedFY2025145.58M +21.2%+19.1%
IMTXImmatics N.V.LTM Mar 2026125.95M +13.3%+21.1%
RCUSArcus Biosciences, Inc.LTM Jun 2026116.35M +19.9%+14.3%
CGENCompugen Ltd.LTM Mar 202694.08M +4.2%+2.7%
IPHAInnate Pharma S.A.FY202589.42M +10.3%+3.9%
XNCRXencor, Inc.LTM Jun 202674.94M +5.1%+7.6%
MGNXMacroGenics, Inc.LTM Mar 202663.26M +0.8%+0.9%
JANXJanux Therapeutics, Inc.LTM Mar 202662.14M +9.2%+14.3%
IMCRImmunocore Holdings plcLTM Mar 202650.99M -0.4%+3.3%
Peer median (excluding IMCR) 105.22M+9.7%+10.9%

Competitors are the stored peer set for IMCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

Mixed currencies
Metric
FY2021
Dec 2021 · GBP
FY2022
Dec 2022 · GBP
FY2023
Dec 2023 · GBP
FY2024
Dec 2024 · USD
FY2025
Dec 2025 · USD
Revenue27.04M144.23M197.39M247.98M297.57M
Cost of Revenue05.29M820.63K5.54M6.21M
Gross Profit27.04M138.94M196.57M242.44M291.36M
Gross Margin100.0%96.3%99.6%97.8%97.9%
Research & Development74.31M84.31M129.42M177.44M204.47M
Selling, General & Admin82.15M0114.35M121.17M120.62M
Operating Expenses156.46M181.71M243.77M298.77M325.09M
Depreciation & Amortization5.63M4.41M3.24M3.36M2.43M
EBITDA(123.58M)(38.35M)(40.87M)(38.5M)387.18K
EBITDA Margin-457.0%-26.6%-20.7%-15.5%0.1%
Operating Income(129.42M)(42.77M)(47.2M)(56.28M)(33.74M)
Operating Margin-478.5%-29.7%-23.9%-22.7%-11.3%
Interest Income65K3.76M14.23M25.62M16.48M
Interest Expense5.57M5.41M4.08M18.84M12.17M
Other Income / Expenses(3.92M)8.95M(982.07K)14.01M19.53M
Income Before Tax(133.34M)(33.82M)(48.19M)(42.32M)(14.21M)
Pre-Tax Margin-493.0%-23.4%-24.4%-17.1%-4.8%
Income Tax Expense111.19K9.65M(4.43M)(1.48M)12.21M
Net Income(133.45M)(43.46M)(43.75M)(40.81M)(26.42M)
Net Margin-493.4%-30.1%-22.2%-16.5%-8.9%
EPS (Basic)(3.13)(0.95)(0.89)(1.02)(0.53)
EPS (Diluted)(3.00)(0.95)(0.89)(1.02)(0.53)
Weighted Avg Shares42.49M45.71M48.89M49.99M50.35M
Weighted Avg Shares (Diluted)43.86M45.71M48.89M49.99M50.35M

Immunocore Holdings plc

NASDAQ:IMCR

Intrinsic Alpha fair value

Locked

Current Price

$27.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.